GLP-1 Drugs from the Gray Market
US$ 24.31
glp-1 drugs and dementia 🧐Will GLP-1RA be the future of altzeimers treatement? 🧠There are multiple studies underway assessing the effectiveness of class of medications in prevention and/or delay of 🧠Alzheimer's makes up 60%-80% GLP-1 Drugs and Brain Health:
Description
Upon approval, information necessary to address the research question will be provided under the terms of a data-sharing agreement
In this study, we used LLMs to augment this approach for characterizing public perceptions about GLP-1 RAs on Reddit
& Lazar, M
Cost effectiveness and equitable access will need careful consideration if GLP-1RAs are to be deployed more broadly in NDDs
